Literature DB >> 14648452

Brazilian response to the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among injection drug users.

Fábio Mesquita1, Denise Doneda, Denise Gandolfi, Maria Inês Battistella Nemes, Tarcísio Andrade, Regina Bueno, Daniela Piconez e Trigueiros.   

Abstract

The Brazilian response to the human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) epidemic is being observed all over the world because of its success. Understanding the role of injection drug users (IDUs) in the epidemic and the political response thereto is a key factor in the control of the epidemic in Brazil. This paper summarizes some of the most important analyses of the Brazilian response to the HIV/AIDS epidemic among and from IDUs. Key elements of the response include the support of the Brazilian Universal Public Health System, the provision of universal access to highly active antiretroviral therapy, and the creation of harm reduction projects that are politically and financially supported by the federal government. The response among and from IDUs is a key element in overall control of the HIV/AIDS epidemic. The response to the epidemic among and from IDUs has been headed in the correct direction since its beginning and is now being intensively expanded.

Entities:  

Mesh:

Year:  2003        PMID: 14648452     DOI: 10.1086/377547

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  8 in total

1.  A public policy approach to local models of HIV/AIDS control in Brazil.

Authors:  Guillaume Le Loup; Andreia de Assis; Maria-Helena Costa-Couto; Jean-Claude Thoenig; Sonia Fleury; Kenneth de Camargo; Bernard Larouzé
Journal:  Am J Public Health       Date:  2009-04-16       Impact factor: 9.308

2.  Short Communication: Current Prevalence and Risk Factors Associated with Human T Lymphotropic Virus Type 1 and Human T Lymphotropic Virus Type 2 Infections Among HIV/AIDS Patients in São Paulo, Brazil.

Authors:  Adele Caterino-de-Araujo; Cláudio Tavares Sacchi; Maria Gisele Gonçalves; Karoline Rodrigues Campos; Mariana Cavalheiro Magri; Wong Kuen Alencar
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01-02       Impact factor: 2.205

3.  HIV treatment outcomes among people who inject drugs in Victoria, Australia.

Authors:  Nick Walsh; Anne Mijch; Kerrie Watson; Handan Wand; Christopher K Fairley; John McNeil; Nick Crofts; Lisa Maher
Journal:  BMC Infect Dis       Date:  2014-12-19       Impact factor: 3.090

4.  The first survey of human T-cell lymphotropic viruses (HTLV) in HIV/AIDS patients in Santa Catarina State, Brazil.

Authors:  Chaiana Esmeraldino Mendes Marcon; Karoline Rodrigues Campos; Gabriela Bassi da Silva; Fabiana Schuelter-Trevisol; Aline Daiane Schlindwein; Daisson José Trevisol; Adele Caterino-de-Araujo
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2019-10-10       Impact factor: 1.846

5.  Distribution of Human Immunodeficiency Virus and Human T-Leukemia Virus Co-infection in Bahia, Brazil.

Authors:  Felicidade Mota Pereira; Fred Luciano Neves Santos; Ângelo Antônio Oliveira Silva; Nathan Menezes Nascimento; Maria da Conceição Chagas Almeida; Roberto Perez Carreiro; Bernardo Galvão-Castro; Maria Fernanda Rios Grassi
Journal:  Front Med (Lausanne)       Date:  2022-01-10

6.  HIV/Aids and COVID-19 in Brazil: in four decades, two antithetical approaches to face serious pandemics.

Authors:  Bernardo Galvão-Castro; Maria Fernanda Rios Grassi; Euclides Ayres de Castilho; Dirceu Bartolomeu Greco
Journal:  Mem Inst Oswaldo Cruz       Date:  2021-06-21       Impact factor: 2.743

7.  Surveillance of human retroviruses in blood samples from patients with hepatitis B and C in São Paulo, Brazil.

Authors:  Adele Caterino-de-Araujo; Karoline Rodrigues Campos; Tamirez Villas Boas Petrucci; Rafael Xavier da Silva; Marcílio Figueiredo Lemos; Regina Célia Moreira
Journal:  Rev Soc Bras Med Trop       Date:  2020-02-07       Impact factor: 1.581

8.  Hepatitis C viral load in HCV-monoinfected and HCV/HIV-1-, HCV/HTLV-1/-2-, and HCV/HIV/HTLV-1/-2-co-infected patients from São Paulo, Brazil.

Authors:  Fabiana Aparecida Alves; Karoline Rodrigues Campos; Marcílio Figueiredo Lemos; Regina Célia Moreira; Adele Caterino-de-Araujo
Journal:  Braz J Infect Dis       Date:  2018-04-04       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.